AstraZeneca Sends Legal Notice to Serum Institute of India over Delays in Vaccine Supply
Serum Institute of India (SII), the busiest vaccine maker in the world as measured by volume in production, apparently now is too busy. And politics could…
Tag: Serum Institute of India
Novavax Makes Big Move Donating 1.1 Billions Doses to Serum Institute of India as part of COVAX Deal
Novavax Inc. (Nasdaq: NVAX) inked a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance (Gavi), to supply up to 1.1 billion cumulative doses of…
India’s Drug Regulator Gives Greenlight for Oxford Vaccine & Covaxin for Emergency Pandemic Use: Some Worry Not Enough Transparency
The Drugs Controller General of India (DCGI) issued emergency authorization for two vaccines, including ‘COVISHIELD’, produced by the Serum Institute of India (SII), which is…
Serum Institute of India Chief Recommends Governments Shield Pharma from Vaccine Lawsuits
TrialSite reported on Nov. 30 that a volunteer participating in the ‘Covishield’ COVID-19 vaccine study in India sued the vaccine producer, Pune-based Serum Institute of…
IAVI & Scripps Antibody IP Basis for Global Deal for Equitable Access to Fight COVID-19
A nonprofit scientific research organization known as IAVI, dedicated to addressing urgent unmet global health challenges, has spent years in a research and development partnership…
Chief of World’s Busiest Vaccine Manufacturer: The USA & China are ‘Crazy’ for Shunning COVAX Alliance
Adar Poonawalla leads perhaps the busiest vaccine production operation in the world. The billionaire and CEO of Serum Institute of India (SII) had some tough words for…
Worlds Largest Vaccine Manufacturer Tightening Up Relationship to Study and Produce AZD1222
The Serum Institute of India (SII) recently partnered up with AstraZeneca and Oxford University to progress COVID vaccine candidate AZD1222 into Phase 2/3 clinical trials. Now…
Serum Institute of India, Gates Foundation & GAVI Partner for COVID-19 Vaccine At Risk Production for $3 Per Dose Low Income Access
India’s Serum Institute of India, the world’s busiest vaccine manufacturer as measured by volume, emerges as a worldwide key player in the battle against COVID-19.…
Indian Council of Medical Research to Launch Major Vaccine Clinical Trials in India
Indian Council of Medical Research announced plans to conduct large-scale clinical trials of two TB vaccines including one developed in India. Involving up to 12,000…